Pediatric Vaccines Market, by Vaccine Type (Monovalent and Multivalent), by Vaccine Form (Attenuated Live Viruses, Inactivated Viruses, Subunits, Toxoids, Recombinant, Polysaccharides and Conjugates), by Application (Infectious Disease and Allergy), By End User (Hospitals, Pediatric Clinics, Research Organizations, and Others), and by Region - Global Forecast to 2026
- Report code : CMI11708 |
- Industry :
Biotechnology
- Published On : May 2018 |
- Pages : 189 Pages |
- Format :
- Request Sample
- Request Customization
Pediatric Vaccines Market – Insights
Pediatric vaccines perform significant role in reduction of various childhood infectious disease such as measles, diphtheria, Poliomyelitis, and Haemophilus influenzae type b (Hib). Increasing adoption of pediatric vaccines have significantly led to increase in global vaccination coverage. According to the World Health Organization (WHO), immunization helps to prevent around 2 to 3 million deaths annually. Moreover, vaccination is the most cost–effective and efficient heath investment, which is accessible to hard-to-reach locations and vulnerable populations. According to the data published by Centers for Disease Control and Prevention (CDC), in April 2014, vaccination was estimated to prevent around 21 million hospitalizations and around 732,000 deaths among children born between 1994 and 2013. High prevalence of infectious disease, combined with increasing numbers of government initiatives for raising awareness regarding immunization and development of novel adjuvants and therapeutic vaccines are expected to drive growth of pediatric vaccines market during the forecast period.
The global pediatric vaccines market was valued at US$ 23,317.0 million in 2017 and is expected to witness a CAGR of 10.8% over the forecast period (2018 – 2026)
Figure 1: Global Pediatric Vaccines Market Value Analysis (US$ Mn), By Region (2017)
Source: Coherent Market Insights Analysis (2018)
Increasing government initiatives for pediatric vaccines are expected to drive growth of the pediatric vaccines market
Increasing engagement by various government healthcare regulatory organization and private organizations in minimizing the pediatric disease, is expected to propel demand for pediatric vaccine over the forecast period. For instance, in 2013, World Health Organization (WHO): Europe launched the flu Awareness Campaign initiative to spread awareness regarding flu among the European population. In 2002, the United Nations Children's Fund (UNICEF) initiated the Social Mobilization Network (SMNet) in India, in order to irradiate the polio from India. According to the data published in the Journal of Infectious Diseases in July 2017, Social Mobilization Network resulted in increasing immunization coverage in the high-risk areas of India from 36% in 2009 to 81% in 2016 in Uttar Pradesh and from 54% in 2009 to 88.5% in 2016 Bihar. Moreover, increasing involvement of various healthcare regulatory organizations in minimizing the pediatric infectious disease is expected to augment growth of the pediatric vaccines market in near future.
Pediatric vaccines contributes in significant reduction of increasing pediatric infectious disease burden. Increasing numbers of vaccine preventable infectious disease are minimized using vaccination programme. However, mortality associated with such infectious disease is reported in some of the countries. Moreover, development of vaccines is expected to minimize the risk of these infectious disease over the forecast period.
For instance, according to the World Health Organization (WHO) May 2018 data findings, measles are constantly present disease in the U.S. since 2000. In December 2014, the U.S. experienced measles outbreak, owing to unvaccinated visitors who can carried the disease in the U.S from other countries or unvaccinated U.S. people returning to U.S. from countries where measles is still common, such as in Europe, Asia Pacific, and Africa. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2014, around 667 measles cases were reported from 27 states in the U.S. to CDC’s National Center for Immunization and Respiratory Diseases (NCIRD). This is the highest number of cases since measles elimination was documented in the U.S. in 2000. According to the same source, in 2017, around 118 people from 15 states of U.S. and the District of Columbia reported measles cases.
Pediatric Vaccines Market Regional Outlook
On the basis of geography, the global pediatric vaccines market is segmented into six major regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to hold strong foothold in this market, owing to high presence of various key pediatric vaccine manufactures, extensive research and development (R&D) by research organizations, and rise in the government supports for immunization and development of pediatric vaccines.
Asia Pacific is expected to emerge as a major market player in the near future, owing to growing engagement of government and private organizations to initiate awareness campaign and nationwide vaccination program. For instance, in February 2017, Government of India in collaboration with The United Nations Children's Fund (UNICEF) and World Health Organization (WHO), initiated the campaign to prevent children from pediatric disease such as measles and rubella. Under the campaign, children aged between nine months and 15 years will be administered the measles-rubella vaccine (MR-VAC).
Some of the major companies operating in the pediatric vaccines market are GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Eli Lilly Company, AstraZeneca plc, Pfizer, Inc., Aventis Pharma Limited, Indian Immunologicals Limited, Zydus Cadila, Panacea Drugs Pvt. Ltd., and Sinovac Biotech Ltd.
Pediatric vaccines are revolutionizing the healthcare industry by providing protection against the severe illnesses, thereby enabling improved heath and reduced family stress. Moreover, childhood immunization is essential step in maintaining high vaccination levels within the population, which prevents outbreaks such as diphtheria, hepatitis A, hepatitis B, influenza, Haemophilus influenzae type b (Hib), measles, and mumps. Various government healthcare organizations such as the United Nations Children's Fund (UNICEF), American Academy of Pediatrics (AAP), and World Health Organization (WHO) are engaged in initiating various immunization awareness programmes to increase vaccination among the pediatric population.
Market Dynamics
The Centers for Disease Control and Prevention (CDC) recommends immunizing children against most of the vaccine preventable disease by the time they are two years old. These resulted in elimination of some of the infectious disease completely in various countries. For instance, Polio and smallpox have been eliminated in the U.S. due to effective vaccination. In March 2014, World Health Organisation (WHO) declared India as polio-free nation.
Increasing prevalence of chronic and infectious disease, along with growing awareness regarding childhood immunization among various developed and emerging economies lead to boost the growth of pediatric vaccines market in near future. Furthermore, increasing alliances, partnership, and collaborations among key players to introduce
efficient vaccines in the market is expected to drive growth of the market in near future.
Key features of the study:
- This report provides in-depth analysis of pediatric vaccines and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global pediatric vaccines market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Eli Lilly Company, AstraZeneca plc, Pfizer, Inc., Aventis Pharma Limited, Indian Immunologicals Limited, Zydus Cadila, Panacea Drugs Pvt. Ltd., and Sinovac Biotech Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The pediatric vaccines market report caters to various stakeholders in this industry including investors, suppliers, pediatric vaccine manufacturers, distributors, new entrants, and financial analysts
Detailed Segmentation:
- Global Pediatric Vaccines Market, By Vaccine Type:
- Monovalent
- Multivalent
- Global Pediatric Vaccines Market, By Vaccine Form:
- Attenuated Live Viruses
- Inactivated Viruses
- Subunits
- Toxoids
- Recombinant
- Polysaccharides
- Conjugates
- Global Pediatric Vaccines Market, By Application:
- Infectious Disease
- Allergy
- Global Pediatric Vaccines Market, By End User:
- Hospitals
- Pediatric Clinics
- Research Organizations
- Others
- Global Pediatric Vaccines Market, By Geography:
- North America
- By Country:
- U.S.
- Canada
- By Vaccine Type:
- Monovalent
- Multivalent
- By Vaccine Form:
- Attenuated Live Viruses
- Inactivated Viruses
- Subunits
- Toxoids
- Recombinant
- Polysaccharides
- Conjugates
- By Application
- Infectious Disease
- Allergy
- By End User:
- Hospitals
- Pediatric Clinics
- Research Organizations
- Others
- Europe
- By Country:
- Germany
- France
- Italy
- UK
- Spain
- Russia
- Rest of Europe
- By Vaccine Type:
- Monovalent
- Multivalent
- By Vaccine Form:
- Attenuated Live Viruses
- Inactivated Viruses
- Subunits
- Toxoids
- Recombinant
- Polysaccharides
- Conjugates
- By Application
- Infectious Disease
- Allergy
- By End User:
- Hospitals
- Pediatric Clinics
- Research Organizations
- Others
- Asia Pacific
- By Country:
- China
- India
- Japan
- South Korea
- Australia
- ASEAN
- Rest of Asia Pacific
- By Vaccine Type:
- Monovalent
- Multivalent
- By Vaccine Form:
- Attenuated Live Viruses
- Inactivated Viruses
- Subunits
- Toxoids
- Recombinant
- Polysaccharides
- Conjugates
- By Application
- Infectious Disease
- Allergy
- By End User:
- Hospitals
- Pediatric Clinics
- Research Organizations
- Others
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Vaccine Type:
- Monovalent
- Multivalent
- By Vaccine Form:
- Attenuated Live Viruses
- Inactivated Viruses
- Subunits
- Toxoids
- Recombinant
- Polysaccharides
- Conjugates
- By Application
- Infectious Disease
- Allergy
- By End User:
- Hospitals
- Pediatric Clinics
- Research Organizations
- Others
- Latin America
- By Country:
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- By Vaccine Type:
- Monovalent
- Multivalent
- By Vaccine Form:
- Attenuated Live Viruses
- Inactivated Viruses
- Subunits
- Toxoids
- Recombinant
- Polysaccharides
- Conjugates
- By Application
- Infectious Disease
- Allergy
- By End User:
- Hospitals
- Pediatric Clinics
- Research Organizations
- Others
- Africa
- By Country:
- South Africa
- Central Africa
- North Africa
- By Vaccine Type:
- Monovalent
- Multivalent
- By Vaccine Form:
- Attenuated Live Viruses
- Inactivated Viruses
- Subunits
- Toxoids
- Recombinant
- Polysaccharides
- Conjugates
- By Application
- Infectious Disease
- Allergy
- By End User:
- Hospitals
- Pediatric Clinics
- Research Organizations
- Others
- Company Profiles
- GlaxoSmithKline plc*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments
- Strategies
- Serum Institute of India Pvt. Ltd.
- Eli Lilly Company
- AstraZeneca plc
- Pfizer, Inc.
- Aventis Pharma Limited
- Indian Immunologicals Limited
- Zydus Cadila
- Panacea Drugs Pvt. Ltd.
- Sinovac Biotech Ltd.
- GlaxoSmithKline plc*
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet By Vaccine Type
- Market Snippet By Vaccine Form
- Market Snippet By Application
- Market Snippet By End-User
- Market Snippet By Region
- Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Epidemiology
- Key Developments
- Awareness Strategies
- Merger and Acquisitions
- Regulatory Scenario
- New Product Approvals/Launch
- PEST Analysis
- Porter’s Analysis
- Global Pediatric Vaccines Market, By Vaccine Type, 2016 - 2026 (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2026 (%)
- Y-O-Y Growth Analysis, 2017 - 2026
- Segment Trends
- Monovalent
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Multivalent
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Global Pediatric Vaccines Market, By Vaccine Form, 2016 - 2026 (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2026 (%)
- Y-O-Y Growth Analysis, 2017 - 2026
- Segment Trends
- Attenuated Live Viruses
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Inactivated Viruses
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Subunits
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Toxoids
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Recombinant
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Polysaccharides
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Conjugates
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Global Pediatric Vaccines Market, By Application, 2016 - 2026 (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2026 (%)
- Y-O-Y Growth Analysis, 2017 - 2026
- Segment Trends
- Infectious Disease
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-O-Y Growth Analysis, 2017 - 2026
- Allergy
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Global Pediatric Vaccines Market, By End-User, 2016 - 2026 (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2026 (%)
- Y-O-Y Growth Analysis, 2017 - 2026
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Pediatric Clinics
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Academic & Research Organizations
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2016 – 2026, (US$ Million)
- Global Pediatric Vaccines Market, By Regions, 2016 - 2026 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2017 and 2026 (%)
- Y-O-Y Growth Analysis, For Regions, 2017 - 2026
- North America
- Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Middle East
- Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- GlaxoSmithKline plc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Serum Institute of India Pvt. Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Eli Lilly Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- AstraZeneca plc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Aventis Pharma Limited
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Indian Immunologicals Limited
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Zydus Cadila
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Panacea Drugs Pvt. Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Sinovac Biotech Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
*Browse 22 market data tables and 39 figures on “Pediatric Vaccines Market - Global forecast to 2026”.
Research Methodology
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
- Primary Research (Trade Surveys and Experts Interviews)
- Desk Research
- Proprietor Data Analytics Model
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
- National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
- Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
- Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
- Trade association, National and international media and trade press.
- Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
- Scientific journals, and other technical magazines and whitepapers.
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Data Standardization:
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
- Micro-economic indicators
- Macro-economic indicators
- Environmental indicators
- Socio-political indicators
- Technology indicators
Data Processing
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
Data Validation
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
- It provides first-hand information on the market dynamics, outlook, and growth parameters.
- Industry experts validates the estimates which helps the company to cement the on-going research study.
- Primary research includes online surveys, face-to face interviews, and telephonic interviews.
The primary research is conducted with the ecosystem players including, but not limited to:
- Raw Material Suppliers
- Manufacturers
- System Integrators
- Distributors
- End-users
Related Insights :
Share
Choose License Type
"How Can I Help You" ?
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Key Benefits
Custom Research Solution
Talk to our research consultant to design an exclusive report as per your research needs.
Customer Fulfilment
We aim to fulfil client's research demands with tailored research solutions.
Quick Turnaround Time Reports
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
360-degree Approach
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
Assured Quality
We strive to provide most accurate and reliable research findings in our research reports.